Dr. Abbey Discusses the Use of VABYSMO® for Polypoidal Choroidal Vasculopathy
In the current issue of Ocular Surgery News on Healio, Texas Retina’s Ashkan M. Abbey, MD, shares his perspective on the recently reported two-year results from the Phase 3b/4 SALWEEN study evaluating
read more
Dr. Choi Develops New Surgical Technique for Macular Holes That Fail to Close After Initial Surgery
Texas Retina’s Rene Y. Choi, MD, PhD, recently published a case report in the medical journal Retinal Cases & Brief Reports describing a surgical technique he developed to treat macular holes that
read more
September is Sports Eye Safety Month
According to Prevent Blindness, there were more than 44,000 sports-related eye injuries treated in the United States in 2025. Basketball had the highest rate of eye injuries for those ages 15 and
read more
Texas Retina Dallas Research Team Recognized for Highest Site Enrollment Globally in Geographic Atrophy Clinical Trial
Under the leadership of Principal Investigator Dr. Ashkan M. Abbey, the Texas Retina Dallas research team was recently named the top enroller for Part I of the DFI18231 study, which is evaluating
read more
Texas Retina’s Anna Brown Selected for Trials InSight Research Coordinator Executive Committee
Texas Retina Clinical Research Coordinator Anna Brown was recently selected by Trials InSight to serve on its new Research Coordinator Executive Committee. Trials InSight is a first-of-its-kind congress focused on the future
read more
New Clinical Trials Available at Texas Retina
Medical researchers continue to make significant advances in the diagnosis and treatment of many retina conditions, discovering new sight-saving treatments for diseases that once robbed patients of their vision. That is why
read more
Texas Retina First in the US to Randomize a Patient in the i-SIGHT2 Bioelectric Therapy for Dry AMD Clinical Trial
The i-SIGHT2 pivotal clinical trial is evaluating the investigational i-Lumen AMD System for patients with intermediate to advanced dry age-related macular degeneration (AMD), and on July 1, 2026, Texas Retina’s Patrick D.
read more Dr. Abbey Participates in ReachMD CME on Sustained-Delivery TKIs for Wet AMD
Texas Retina’s Ashkan M. Abbey, MD, recently participated in a continuing medical education (CME) program through ReachMD, titled, “Redefining Durability in nAMD: The Science and Strategy of Sustained-Delivery TKIs.” During the program,
read more
What is a Vitrectomy?
Texas Retina physicians perform vitrectomy, a surgical procedure that carefully removes the vitreous gel that fills the posterior segment of the eye, to correct a number of eye problems, including: Retinal detachments
read more
Dr. Abbey Spoke About Vitrectomy and Light Adjustable Lenses at ASRS 2026
Texas Retina’s Ashkan Abbey, MD, FASRS, FAAO, participated in a panel discussion on the impact of vitrectomy on light adjustable lenses before final laser lock-in in post-cataract surgery patients at the 44th
read more